Dana Farber Cancer Institute President and CEO Laurie Glimcher is stepping down October 1st. In 2016, she became the first woman to lead Dana Farber in its 77 year history.
“Eight years ago, I began this journey with a deep appreciation for the extraordinary research that emanated from Dana-Farber since its earliest days and the clinical excellence that Dana-Farber provides patients and families,” said Glimcher. “And now, as I reflect on my tenure, I am intensely proud of what we have achieved in providing world class care for our patients, leading in innovation, and discovering new treatments and cures.”
She will be succeeded by oncologist and researcher Benjamin Ebert.
“I’m extraordinarily honored to be selected as the next president and CEO of Dana-Farber and to build on the exceptional leadership and accomplishments of Laurie Glimcher,” said Ebert. “Dana-Farber is truly a remarkable organization and a global leader in innovation, and in caring and advocating for cancer patients. Together with our executive leadership team, I will continue to advance a patient-first model as we open this new chapter.”
Dr Glimcher says this is the perfect time to be passing the torch.
(Photos provided by Dana Farber Cancer Institute)